norfloxacin has been researched along with Failure to Thrive in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Failure to Thrive: A condition of substandard growth or diminished capacity to maintain normal function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khoshoo, V | 1 |
| Raj, P | 1 |
| Srivastava, R | 1 |
| Bhan, MK | 1 |
1 other study available for norfloxacin and Failure to Thrive
| Article | Year |
|---|---|
Salmonella typhimurium-associated severe protracted diarrhea in infants and young children.
Topics: Amikacin; Combined Modality Therapy; Diarrhea, Infantile; Failure to Thrive; Female; Fluid Therapy; | 1990 |